Evidence map›Paper›PMID 39055614›Full record

ArticleHealth science reports2024

The clinical manifestations and treatment outcomes of Behçet's disease: A single-center experience.

Karokh F Hama Hussein, Hiwa O Abdullah, Shaho F Ahmed, Aso N Qadir, Hoshmand R Asaad, Fattah H Fattah, Bnar J Hama Amin, Dana T Gharib, Shvan H Mohammed, Rawezh Q Salih and 3 more

Abstract read
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Karokh F Hama HusseinSmart Health Tower Sulaimani Iraq.
Hiwa O AbdullahSmart Health Tower Sulaimani Iraq.
Shaho F AhmedSmart Health Tower Sulaimani Iraq.
Aso N QadirSmart Health Tower Sulaimani Iraq.
Hoshmand R AsaadSmart Health Tower Sulaimani Iraq.
Fattah H FattahSmart Health Tower Sulaimani Iraq.
Bnar J Hama AminSmart Health Tower Sulaimani Iraq.
Dana T GharibSmart Health Tower Sulaimani Iraq.
Shvan H MohammedKscien Organization Sulaimani Iraq.
Rawezh Q SalihSmart Health Tower Sulaimani Iraq.
Berun A AbdallaSmart Health Tower Sulaimani Iraq.
Fahmi H KakamadSmart Health Tower Sulaimani Iraq.ORCID 0000-0002-2124-9580
Shorsh A MohammedSmart Health Tower Sulaimani Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Behçet's disease is a chronic, multisystemic, and relapsing inflammatory disorder. It lacks a permanent cure, the focus of treatment is on mitigating symptoms, decreasing the frequency and severity of relapses, and preventing life-threatening complications. This study aims to report the experience of a single center in managing patients with Behçet's disease and discuss the treatment outcomes. Methods: This study was a retrospective case series conducted over 2 years. All cases were clinically diagnosed according to the International Criteria for Behçet's Disease. The extracted data were demographics, family history, clinical findings, criteria scores, treatment, and outcomes. Results: A total of 31 patients were included, consisting of 13 males (42%) and 18 females (58%). Most cases were over the age of 30, and both genders were nearly equally distributed among age groups. The most commonly affected site was the oral cavity, observed in 96.77% of cases. Genital, cutaneous, and vascular involvements were more common in males, while females were more likely to have oral, ocular, and musculoskeletal involvements. For various treatment regimens, oral, cutaneous, vascular, and musculoskeletal involvements showed complete response in all cases. Among cases with genital involvement, complete response was achieved in seven cases (41.2%), while four cases (23.5%) showed only partial response, and six cases (35.3%) experienced recurrence. In cases with ocular involvement, only partial responses were observed. Conclusion: Oral, cutaneous, vascular, and musculoskeletal involvements may have a higher likelihood of a complete response to treatment regimens. However, genital involvement may be the most recurrent manifestation, followed by ocular involvement.

Indexed as

autoimmune diseaseBehcet diseaseChronic diseaseinflammatory disorder

Identifiers

PMID39055614
PMCPMC11269204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.